Behcet's disease: from east to west

被引:207
|
作者
Davatchi, Fereydoun [1 ]
Shahram, Farhad [1 ]
Chams-Davatchi, Cheyda [1 ]
Shams, Hormoz [1 ]
Nadji, Abdolhadi [1 ]
Akhlaghi, Massoomeh [1 ]
Faezi, Tahereh [1 ]
Ghodsi, Zahra [1 ]
Faridar, Alireza [1 ]
Ashofteh, Farima [1 ]
Abdollahi, Bahar Sadeghi [1 ]
机构
[1] Univ Tehran Med Sci, Shariati Hosp, Rheumatol Res Ctr, Behcets Dis Unit, Tehran 14114, Iran
关键词
Behcet's disease; ASSOCIATION; POPULATION; INVOLVEMENT; GENE;
D O I
10.1007/s10067-010-1430-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet's disease (BD) is classified among vasculitides. There are actually five nationwide surveys of BD: Iran, Japan, China, Korea, and Germany. Among case series, four are on more than 200 cases (Turkey, Morocco, Tunisia, and UK). BD was classically seen around the Silk Route. Now, it is seen everywhere. The male to female ratios were, respectively (in nationwide surveys), 1.19, 0.98, 1.34, 0.63, and 1.40 to 1. The mean age at onset was 26.2, 35.7, 33.8, 29, and 26 years. Major manifestations were seen, respectively, in nationwide surveys: mucous membrane (oral aphthosis in 97%, 98%, 98%, 99%, and 98%; genital aphthosis in 65%, 73%, 76%, 83%, and 64%); skin manifestations (pseudo-folliculitis in 57%, N/A, 31%, N/A, and 62%; erythema nodosum in 22%, N/A, 38%, N/A, and 42%; ocular manifestations in 55%, 69%, 35%, 51%, and 53%). Minor manifestations were seen, respectively, in nationwide surveys: joint manifestations in 33%, 57%, 30%, 38%, and 53%; neurological manifestations in 9%, 11%, 6.5%, 4.6%, and 11%; gastrointestinal manifestations in 7%, 15.5%, 9%, 7.3%, and 12%; vascular involvement in 8.9%, 8.9%, 7.7%, 1.8%, and 13%; pulmonary manifestations in 0.3%, N/A, 2.2%, N/A, and 3.6%; cardiac manifestations in 0.5%, N/A, 4%, N/A, and 3.2%. Laboratory tests are not useful except the pathergy test, which was positive in 54%, 44%, N/A, 40%, and 34% of cases. ESR was normal in many patients. Diagnosis is based upon clinical manifestations. The International Criteria for Behcet's Disease (ICBD, 2006) may be of help, having a sensitivity of 98.2% and a specificity of 95.6% in Iranian patients.
引用
收藏
页码:823 / 833
页数:11
相关论文
共 50 条
  • [31] Behcet's disease
    Marshall, SE
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2004, 18 (03): : 291 - 311
  • [32] Behcet's disease or Adamantiades-Behcet disease? An evidence-based historical survey
    Evereklioglu, Cem
    MEDICAL SCIENCE MONITOR, 2010, 16 (06): : RA136 - RA142
  • [33] Behcet’s disease
    S. A. Al-Mutawa
    S. M. Hegab
    Clinical and Experimental Medicine, 2004, 4 : 103 - 131
  • [34] Behcet's disease
    Cacoub, Patrice
    Vieira, Matheus
    Bodaghi, Bahram
    Saadoun, David
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2025, 209 (02): : 301 - 309
  • [35] Behcet's disease
    Kurokawa, MS
    Yoshikawa, H
    Suzuki, N
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 25 (05) : 557 - 568
  • [36] Behcet's Disease
    Adisen, Esra
    Temel, Berkay
    GAZI MEDICAL JOURNAL, 2019, 30 (02): : 221 - 226
  • [37] Behcet's disease
    Saadoun, D.
    REVUE DE MEDECINE INTERNE, 2023, 44 : A299 - A301
  • [38] Behcet's disease
    Nair, Jagdish R.
    Moots, Robert J.
    CLINICAL MEDICINE, 2017, 17 (01) : 71 - 77
  • [39] Behcet's disease
    Kaklamani, VG
    Vaiopoulos, G
    Kaklamanis, PG
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1998, 27 (04) : 197 - 217
  • [40] Neurological manifestations of Behcet's disease in Japan: a study of 54 patients
    Ideguchi, Haruko
    Suda, Akiko
    Takeno, Mitsuhiro
    Kirino, Yohei
    Ihata, Atsushi
    Ueda, Atsuhisa
    Ohno, Shigeru
    Baba, Yasuhisa
    Kuroiwa, Yoshiyuki
    Ishigatsubo, Yoshiaki
    JOURNAL OF NEUROLOGY, 2010, 257 (06) : 1012 - 1020